High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours

British Journal of Cancer
E VenetsanakosJ M Skinner

Abstract

Despite the presence of a lymphocytic infiltrate in solid cancers, the failure for tumour growth to be contained suggests an inadequate immune response to the tumour. Poor cytotoxicity exerted by tumour-infiltrating lymphocytes (TILs) against tumour cells in vitro, combined with continued tumour growth in vivo, suggests deficiencies in TIL function or numbers. Various theories have been postulated to explain how tumour cells may escape immunosurveillance and control. One of the many hypotheses is the failure of production of cytokines, which are necessary for T cells to mediate their function. Thus, the expression of cytokine mRNA in human breast tumour sections was investigated by reverse transcriptase polymerase chain reaction (RT-PCR) with cytokine-specific primers. A relatively consistent finding was detection of interleukin (IL) 10 mRNA among the tumours. No IL-2 and little IL-4 mRNA was detected in the tumours. IL-6 and IL-10 mRNA was detected in only one and two of the normal breast tissues respectively. IL-2, IL-4 and tumour necrosis factor (TNF)-alpha mRNA was not detected in any of the normal breast tissues. The reduced function of TILs may be related to IL-10, which has known inhibitory effects on T-cell activation.

Citations

May 20, 2006·Cancer Immunology, Immunotherapy : CII·Mingzhong ZhengSunil Chada
May 19, 2006·Expert Opinion on Biological Therapy·Alberto Pinzon-CharryJosé Alejandro López
Jan 31, 2007·Breast Cancer Research : BCR·Carine ChaveyGwendal Lazennec
Dec 3, 2009·International Immunology·Praveen DeepakArbind Acharya
Nov 8, 2011·Breast Cancer Research and Treatment· HamidullahRituraj Konwar
Sep 22, 2016·Indian Journal of Surgical Oncology·Hemanga Kumar BhattacharjeeMahesh C Misra
May 20, 2018·Scientific Reports·Marcio MatsumotoRaquel C R Martinez
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·A NeunerJ R Fischer
Dec 6, 2011·Immunologic Research·Takami SatoSenthamil R Selvan
Jul 5, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Salwa SabetMona M Mohamed
Jan 17, 2017·Clinical Oral Investigations·Songbo TianDong Ma
Nov 16, 2005·International Journal of Cancer. Journal International Du Cancer·Teruhisa SakamotoMasahide Ikeguchi
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Peng H Tan, Amrit S Lota
Jul 25, 2008·Journal of Cancer Research and Clinical Oncology·Leticia Llanes-FernándezCristina Rodríguez-Padilla
Sep 12, 2014·Scientific Reports·Dong MaOu Li
Sep 2, 1998·Immunology and Cell Biology·C OliveM C Falk
Jul 5, 2005·Expert Opinion on Investigational Drugs·D W Miles, J Taylor-Papadimitriou
Dec 2, 2020·International Reviews of Immunology·Elaheh ArianfarAli Memarian
May 26, 1999·Pharmacology & Therapeutics·D W Miles, J Taylor-Papadimitriou
Oct 30, 1999·Respiratory Medicine·H YanagawaS Sone
Jun 2, 1998·Cancer Treatment Reviews·T A Plunkett, D W Miles
Oct 11, 2005·Drug Discovery Today·Evelyn WolfPatrick A Baeuerle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.